Skip to main content

Advertisement

Table 1 Univariate and multivariate analysis for overall survival

From: MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma

Clinical variables HR (95% CI) P-value
Univariate analysis   
Age 1.021(0.823-1.346) 0.886
Sex 0.953(0.545-1.875) 0.754
HBV 1.067(0.513-2.184) 0.864
Cirrhosis 1.652(0.738-3.678) 0.237
Tumor size 1.542(1.136-2.246) 0.087
Tumor number 2.421(1.546-4.439) 0.246
TNM stage 2.876(1.873-4.786) 0.002
Histology grade 1.724(1.120-2.863) 0.027
PVTT 3.539(2.238-7.731) 0.017
AFP 2.535(1.347-5.042) 0.027
miR-503 expression 2.942(1.857-4.974) 0.001
Multivariate analysis   
TNM stage 2.054(1.573-4.853) 0.015
Histology grade 1.431(0.690-2.968) 0.336
PVTT 0.549(0.242-1.246) 0.152
AFP 1.147(0.575-2.288) 0.697
miR-503 expression 2.461(1.106-4.623) 0.005
  1. HR Hazard ratios, CI confidence interval, HBV Hepatitis B virus, TNM tumor-node-metastasis, PVTT portal vein tumor thrombi, AFP Alpha-fetoprotein, Boldface P values indicate statistical significant.